Cargando…

Results of a community-based screening programme for chronic kidney disease and associated risk factors, (obesity, diabetes and hypertension) in a Samoan cohort

OBJECTIVES: In 2019, under the World Kidney Day theme of ‘Kidney health for everyone everywhere’, the National Kidney Foundation of Samoa undertook an extensive community screening campaign to detect the estimated prevalence of chronic kidney disease (CKD) and its associated risk factors in the comm...

Descripción completa

Detalles Bibliográficos
Autores principales: Tafuna'i, Malama, Turner, Robin, Matalavea, Ben, Voss, David, Hazelman, Lose, Richards, Rosalina, Walker, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996012/
https://www.ncbi.nlm.nih.gov/pubmed/35396298
http://dx.doi.org/10.1136/bmjopen-2021-056889
_version_ 1784684408958091264
author Tafuna'i, Malama
Turner, Robin
Matalavea, Ben
Voss, David
Hazelman, Lose
Richards, Rosalina
Walker, Robert
author_facet Tafuna'i, Malama
Turner, Robin
Matalavea, Ben
Voss, David
Hazelman, Lose
Richards, Rosalina
Walker, Robert
author_sort Tafuna'i, Malama
collection PubMed
description OBJECTIVES: In 2019, under the World Kidney Day theme of ‘Kidney health for everyone everywhere’, the National Kidney Foundation of Samoa undertook an extensive community screening campaign to detect the estimated prevalence of chronic kidney disease (CKD) and its associated risk factors in the community. SETTING: Fifteen screening sites, with 11 urban and rural sites on the main island of Upolu, and 4 in different rural areas on the island of Savaii. PARTICIPANTS: All participants were self-referrals to the various screening sites. In total, 1163 Samoans were screened, with similar numbers from both urban and rural areas and similar numbers of female and male. SCREENING ACTIVITIES: All participants were screened for CKD using point of care serum creatinine determinations, with calculation of estimated glomerular filtration rate using the CKD-EPI formula and dipstix urinalysis. A standardised screening survey was used to capture demographic and medical history with associated risk factors of obesity, diabetes, using point of care determination of HbA1c and hypertension. Logistic regression was used to investigate the association of CKD with risk factors. RESULTS: In total, 1163 people were screened for CKD within the month of March 2019. The prevalance of CKD (grades 1–5) was 44.5% (95% CI 41.6% to 47.4) with individual grade prevalence CKD 1: 3.7%, CKD 2: 6.1%, CKD 3: 30.7%, CKD 4: 2.9% and CKD 5: 1.0%. The prevalence of obesity (body mass index ≥32), diabetes and hypertension was 66.3%, 30.8% and 54.3%, respectively. CONCLUSIONS: This is the first paper to report the estimated prevalence of CKD in Samoa or any other Pacific Island nation. It reveals an urgent need for further studies on the epidemiology of CKD in Samoa, to develop country-specific prevention strategies to mitigate this growing burden and prevent subsequent CKD associated complications including development of kidney failure and premature death.
format Online
Article
Text
id pubmed-8996012
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-89960122022-04-27 Results of a community-based screening programme for chronic kidney disease and associated risk factors, (obesity, diabetes and hypertension) in a Samoan cohort Tafuna'i, Malama Turner, Robin Matalavea, Ben Voss, David Hazelman, Lose Richards, Rosalina Walker, Robert BMJ Open Renal Medicine OBJECTIVES: In 2019, under the World Kidney Day theme of ‘Kidney health for everyone everywhere’, the National Kidney Foundation of Samoa undertook an extensive community screening campaign to detect the estimated prevalence of chronic kidney disease (CKD) and its associated risk factors in the community. SETTING: Fifteen screening sites, with 11 urban and rural sites on the main island of Upolu, and 4 in different rural areas on the island of Savaii. PARTICIPANTS: All participants were self-referrals to the various screening sites. In total, 1163 Samoans were screened, with similar numbers from both urban and rural areas and similar numbers of female and male. SCREENING ACTIVITIES: All participants were screened for CKD using point of care serum creatinine determinations, with calculation of estimated glomerular filtration rate using the CKD-EPI formula and dipstix urinalysis. A standardised screening survey was used to capture demographic and medical history with associated risk factors of obesity, diabetes, using point of care determination of HbA1c and hypertension. Logistic regression was used to investigate the association of CKD with risk factors. RESULTS: In total, 1163 people were screened for CKD within the month of March 2019. The prevalance of CKD (grades 1–5) was 44.5% (95% CI 41.6% to 47.4) with individual grade prevalence CKD 1: 3.7%, CKD 2: 6.1%, CKD 3: 30.7%, CKD 4: 2.9% and CKD 5: 1.0%. The prevalence of obesity (body mass index ≥32), diabetes and hypertension was 66.3%, 30.8% and 54.3%, respectively. CONCLUSIONS: This is the first paper to report the estimated prevalence of CKD in Samoa or any other Pacific Island nation. It reveals an urgent need for further studies on the epidemiology of CKD in Samoa, to develop country-specific prevention strategies to mitigate this growing burden and prevent subsequent CKD associated complications including development of kidney failure and premature death. BMJ Publishing Group 2022-04-08 /pmc/articles/PMC8996012/ /pubmed/35396298 http://dx.doi.org/10.1136/bmjopen-2021-056889 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Renal Medicine
Tafuna'i, Malama
Turner, Robin
Matalavea, Ben
Voss, David
Hazelman, Lose
Richards, Rosalina
Walker, Robert
Results of a community-based screening programme for chronic kidney disease and associated risk factors, (obesity, diabetes and hypertension) in a Samoan cohort
title Results of a community-based screening programme for chronic kidney disease and associated risk factors, (obesity, diabetes and hypertension) in a Samoan cohort
title_full Results of a community-based screening programme for chronic kidney disease and associated risk factors, (obesity, diabetes and hypertension) in a Samoan cohort
title_fullStr Results of a community-based screening programme for chronic kidney disease and associated risk factors, (obesity, diabetes and hypertension) in a Samoan cohort
title_full_unstemmed Results of a community-based screening programme for chronic kidney disease and associated risk factors, (obesity, diabetes and hypertension) in a Samoan cohort
title_short Results of a community-based screening programme for chronic kidney disease and associated risk factors, (obesity, diabetes and hypertension) in a Samoan cohort
title_sort results of a community-based screening programme for chronic kidney disease and associated risk factors, (obesity, diabetes and hypertension) in a samoan cohort
topic Renal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996012/
https://www.ncbi.nlm.nih.gov/pubmed/35396298
http://dx.doi.org/10.1136/bmjopen-2021-056889
work_keys_str_mv AT tafunaimalama resultsofacommunitybasedscreeningprogrammeforchronickidneydiseaseandassociatedriskfactorsobesitydiabetesandhypertensioninasamoancohort
AT turnerrobin resultsofacommunitybasedscreeningprogrammeforchronickidneydiseaseandassociatedriskfactorsobesitydiabetesandhypertensioninasamoancohort
AT matalaveaben resultsofacommunitybasedscreeningprogrammeforchronickidneydiseaseandassociatedriskfactorsobesitydiabetesandhypertensioninasamoancohort
AT vossdavid resultsofacommunitybasedscreeningprogrammeforchronickidneydiseaseandassociatedriskfactorsobesitydiabetesandhypertensioninasamoancohort
AT hazelmanlose resultsofacommunitybasedscreeningprogrammeforchronickidneydiseaseandassociatedriskfactorsobesitydiabetesandhypertensioninasamoancohort
AT richardsrosalina resultsofacommunitybasedscreeningprogrammeforchronickidneydiseaseandassociatedriskfactorsobesitydiabetesandhypertensioninasamoancohort
AT walkerrobert resultsofacommunitybasedscreeningprogrammeforchronickidneydiseaseandassociatedriskfactorsobesitydiabetesandhypertensioninasamoancohort